Alumis (ALMS) News Today $4.75 +0.36 (+8.20%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$4.75 0.00 (0.00%) As of 08/15/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ALMS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Alumis (NASDAQ:ALMS) Given New $22.00 Price Target at Morgan StanleyAugust 17 at 8:57 AM | marketbeat.comMorgan Stanley Issues Pessimistic Forecast for Alumis (NASDAQ:ALMS) Stock PriceAugust 17 at 2:45 AM | americanbankingnews.comAlumis (NASDAQ:ALMS) Stock Rating Upgraded by Wall Street ZenAugust 17 at 2:30 AM | marketbeat.comAnalysts’ Opinions Are Mixed on These Materials Stocks: Alumis Inc. (ALMS) and Mosaic Co (MOS)August 16 at 2:44 PM | theglobeandmail.comAlumis Inc. Beat Analyst Profit Forecasts, And Analysts Have New EstimatesAugust 16 at 9:44 AM | finance.yahoo.comAlumis' (ALMS) "Buy" Rating Reiterated at HC WainwrightAugust 16 at 8:06 AM | marketbeat.comAlumis (NASDAQ:ALMS) Upgraded by Wall Street Zen to Hold RatingAugust 16 at 3:37 AM | americanbankingnews.comAlumis Inc. (NASDAQ:ALMS) Receives $19.80 Average PT from BrokeragesAugust 16 at 2:02 AM | americanbankingnews.comAlumis (NASDAQ:ALMS) Announces Earnings ResultsAugust 15 at 11:59 PM | marketbeat.comAlumis Inc. (NASDAQ:ALMS) Given Average Recommendation of "Buy" by BrokeragesAugust 14 at 2:27 AM | marketbeat.comAlumis Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 13, 2025 | globenewswire.comWhile institutions invested in Alumis Inc. (NASDAQ:ALMS) benefited from last week's 4.1% gain, individual investors stood to gain the mostAugust 10, 2025 | finance.yahoo.comAlumis (ALMS) Expected to Announce Earnings on TuesdayAugust 10, 2025 | americanbankingnews.comAlumis Inc. Concludes 2025 Annual Stockholders MeetingAugust 8, 2025 | theglobeandmail.comAlumis (ALMS) to Release Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comAlumis (ALMS) Merges with ACELYRINJuly 29, 2025 | msn.comAlumis (NASDAQ:ALMS) Coverage Initiated by Analysts at Wells Fargo & CompanyJuly 26, 2025 | marketbeat.comAlumis (NASDAQ:ALMS) Given "Buy" Rating at HC WainwrightJuly 26, 2025 | marketbeat.comWells Fargo Initiates Coverage of Alumis (ALMS) with Overweight RecommendationJuly 26, 2025 | msn.comAlumis Inc. Completes Patient Enrollment in LUMUS Phase 2b Trial of ESK-001 for Systemic Lupus Erythematosus, Topline Data Expected Q3 2026July 24, 2025 | quiverquant.comQAlumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus ErythematosusJuly 24, 2025 | globenewswire.comAlumis Inc. (NASDAQ:ALMS) Receives Consensus Recommendation of "Buy" from BrokeragesJuly 19, 2025 | marketbeat.comAlumis (NASDAQ:ALMS) Stock Price Up 2% - Here's What HappenedJuly 18, 2025 | marketbeat.comAlumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate SecretaryJuly 14, 2025 | globenewswire.comFY2025 EPS Estimates for Alumis Lowered by Cantor FitzgeraldJune 19, 2025 | marketbeat.comAlumis (ALMS) Projected to Post Quarterly Earnings on WednesdayJune 11, 2025 | marketbeat.comCantor Fitzgerald Estimates Alumis FY2026 EarningsJune 10, 2025 | marketbeat.comAlumis (NASDAQ:ALMS) Coverage Initiated by Analysts at GuggenheimJune 10, 2025 | marketbeat.comAlumis Target of Unusually Large Options Trading (NASDAQ:ALMS)June 4, 2025 | marketbeat.comAlumis Inc.: Alumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the ...May 31, 2025 | finanznachrichten.deAlumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the Treatment of ...May 31, 2025 | seekingalpha.comAlumis Inc. (NASDAQ:ALMS) Given Consensus Rating of "Buy" by AnalystsMay 31, 2025 | marketbeat.comAnalysts' Revenue Estimates For Alumis Inc. (NASDAQ:ALMS) Are Surging HigherMay 29, 2025 | finance.yahoo.comAlumis to Present at the Jefferies Global Healthcare Investor ConferenceMay 29, 2025 | globenewswire.comAlumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the Treatment of Moderate-to-Severe Plaque PsoriasisMay 29, 2025 | globenewswire.comFY2026 Earnings Forecast for Alumis Issued By HC WainwrightMay 27, 2025 | marketbeat.comAlumis completes merger with ACELYRIN, extends cash runwayMay 22, 2025 | uk.investing.comAlumis Inc. Completes Merger with ACELYRIN, Inc.May 21, 2025 | tipranks.comAlumis Completes Merger with ACELYRINMay 21, 2025 | globenewswire.comAlumis Inc. (NASDAQ:ALMS) Shares Bought by Tang Capital Management LLCMay 20, 2025 | marketbeat.comAlumis Inc. Reports Q1 2025 Financial Results and Strategic ProgressMay 15, 2025 | tipranks.comACELYRIN, Inc. Stockholders Approve Merger Agreement with Alumis Inc.May 15, 2025 | nasdaq.comACELYRIN shareholders approve Alumis merger dealMay 15, 2025 | uk.investing.comAlumis wins shareholder nod for ACELYRIN mergerMay 15, 2025 | investing.comAlumis Inc. Stockholders Approve Merger with ACELYRIN, INC.May 15, 2025 | nasdaq.comAlumis Reports First Quarter 2025 Financial Results and Highlights Recent AchievementsMay 14, 2025 | globenewswire.comHow a Peninsula biotech's merger drama overcame several investor headachesMay 13, 2025 | bizjournals.comAlumis Stockholders Approve Merger with ACELYRINMay 13, 2025 | globenewswire.comForesite Capital Management V LLC Has $45.43 Million Stake in Alumis Inc. (NASDAQ:ALMS)May 12, 2025 | marketbeat.comWednesday 5/7 Insider Buying Report: ALMS, FCNCAMay 9, 2025 | nasdaq.com Get Alumis News Delivered to You Automatically Sign up to receive the latest news and ratings for ALMS and its competitors with MarketBeat's FREE daily newsletter. Email Address ALMS Media Mentions By Week ALMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALMS News Sentiment▼0.260.65▲Average Medical News Sentiment ALMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALMS Articles This Week▼154▲ALMS Articles Average Week Get Alumis News Delivered to You Automatically Sign up to receive the latest news and ratings for ALMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GPCR News SYRE News CRON News AKBA News ELVN News PHAR News IMNM News MLYS News TRVI News UPB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALMS) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alumis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alumis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access